What does CUSIP 45782T105 represent in this 13F holders report?

CUSIP 45782T105 is the security identifier for INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in Q2 2022?

34 institutional investors reported INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share for Q2 2022. Use the holders table for investor-level position and value details.

Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 27,969,231
Total 13F shares: 2,010,894
Share change: -283,340
Total reported value: $17,633,536
Put/Call ratio: 0%
Price per share: $8.84
Number of holders: 34
Value change: -$2,412,787
Number of buys: 14
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 45782T105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Xencor Inc	3/4/5	10%+ Owner	— class O/S missing	1,885,533	$13,104,454	—	03 Sep 2021	3/4/5
VANGUARD GROUP INC	13F	Company	2%	553,638	$4,661,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	1.1%	300,478	$2,530,000	—	31 Mar 2022	13F
Janney Montgomery Scott LLC	13F	Company	0.93%	260,710	$2,195,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	0.83%	231,999	$1,953,000	—	31 Mar 2022	13F
ACT CAPITAL MANAGEMENT, LLC	13F	Company	0.82%	230,500	$1,941,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.46%	127,529	$1,073,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.38%	106,048	$893,000	—	31 Mar 2022	13F
MARSHALL WACE, LLP	13F	Company	0.24%	67,373	$568,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.19%	52,042	$438,000	—	31 Mar 2022	13F
ROYAL BANK OF CANADA	13F	Company	0.18%	51,606	$434,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.13%	37,663	$317,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.13%	35,950	$303,000	—	31 Mar 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	0.12%	33,100	$279,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	26,466	$223,000	—	31 Mar 2022	13F
Westside Investment Management, Inc.	13F	Company	0.09%	26,390	$222,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.09%	23,954	$202,000	—	31 Mar 2022	13F
SIMPLEX TRADING, LLC	13F	Company	0.08%	23,115	$194,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.07%	19,905	$168,000	—	31 Mar 2022	13F
Fermata Advisors, LLC	13F	Company	0.07%	19,586	$165,000	—	31 Mar 2022	13F
ALPS ADVISORS INC	13F	Company	0.07%	18,363	$155,000	—	31 Mar 2022	13F
Financial Advocates Investment Management	13F	Company	0.05%	15,167	$128,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.05%	14,216	$120,000	—	31 Mar 2022	13F
YorkBridge Wealth Partners, LLC	13F	Company	0.04%	10,369	$87,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	3,558	$30,000	—	31 Mar 2022	13F
Leonteq Securities AG	13F	Company	0.01%	2,800	$23,576	—	31 Mar 2022	13F
Covington Capital Management	13F	Company	0%	1,000	$8,000	—	31 Mar 2022	13F
VALLEY NATIONAL ADVISERS INC	13F	Company	0%	1,000	$8,000	—	31 Mar 2022	13F
Asset Dedication, LLC	13F	Company	0%	814	$7,000	—	31 Mar 2022	13F
FNY Investment Advisers, LLC	13F	Company	0%	500	$4,000	—	31 Mar 2022	13F
High Net Worth Advisory Group LLC	13F	Company	0%	500	$4,000	—	31 Mar 2022	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0%	400	$3,368	—	31 Mar 2022	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0%	269	$2,000	—	31 Mar 2022	13F
IFP Advisors, Inc	13F	Company	0%	184	$1,000	—	31 Mar 2022	13F
Cordasco Financial Network	13F	Company	0%	100	$1,000	—	31 Mar 2022	13F

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2022

As of 30 Jun 2022, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,010,894 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Janney Montgomery Scott LLC, MORGAN STANLEY, ACT CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, ROYAL BANK OF CANADA, STATE STREET CORP, and UBS Group AG. This page lists 35 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.